Key result
ICD pacing triggered by SVT linked to VT requiring intervention in two cases.
Case Report (n=2)
Answers are grounded in this paper and cite their sources.
Automatic cardioverter-defibrillators may misdiagnose supraventricular arrhythmias and deliver inappropriate antitachycardia pacing, potentially inducing ventricular tachycardia.
New technology has produced automatic cardioverter-defibrillators capable of delivering antitachycardia pacing, as well as low and high energy shocks and backup bradycardia pacing. These expanded treatment options have led to a wider range of clinical applications for such devices, including the treatment of ventricular tachycardias with longer cycle lengths, which may overlap the cycle lengths of some supraventricular arrhythmias. The diagnostic capability of these devices, although improved, has not advanced sufficiently to ensure reliable discrimination between all supraventricular and ventricular arrhythmias. Two cases are presented in which device-mediated pacing therapy, triggered by supraventricular arrhythmias, induced ventricular tachycardia requiring additional therapeutic intervention. This report illustrates the therapeutic versatility and some of the potential pitfalls, of the recently developed devices and reviews the status of automatic arrhythmia identification technology.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (1991) conducted a case report in Supraventricular arrhythmias in patients with automatic cardioverter-defibrillators (n=2). Automatic cardioverter-defibrillators was evaluated on Induction of ventricular tachycardia requiring additional therapeutic intervention. Device-mediated pacing therapy from automatic cardioverter-defibrillators, triggered by supraventricular arrhythmias, induced ventricular tachycardia requiring additional intervention in two cases.
Synapse has enriched 10 related papers. Consider them for comparative context: